Market Overview:
The global bioinks market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for tissue engineering and regenerative medicine applications, rising investments in research and development activities for novel bioinks, and growing number of conferences and symposia on 3D printing technology. However, the high cost of bioinks may restrain the growth of this market to some extent. Based on type, matrix bioinks accounted for the largest share of the global bioinks market in 2017. Matrix bioinks are mainly used as support materials for cell culturing or printing tissues or organs. They provide structural integrity to printed tissues or organs and help cells attach themselves firmly onto them. Sacrificial Bioink is another type of biomaterial that is gaining popularity due to its ability to dissolve completely after use without leaving any residue behind. It can be used as a sacrificial material in 3D bioprinting processes where it is first deposited into a desired shape followed by cells deposition over it. Support Bioink are also witnessing high demand due to their abilityto support cell proliferationand differentiationin vitro .
Product Definition:
Bioinks are composed of biomaterials and biocompatible solvents. They are used in 3D printing to produce tissues and organs from cells. Bioinks can be tailored to the needs of each individual patient, allowing for the production of customized tissue implants.
Matrix Bioinks:
Bioink is a material that can be injected into the body and used by cells to carry out their functions. Matrix bioinks are one of the most common types of bio-injectables. They consist of highly concentrated proteins, vitamins, minerals and other nutrients that help in repairing damaged cells or tissues in the human body.
Sacrificial Bioinks:
Sacrificial bioinks are materials that can be used to create a physical link between the desired biological target and the nanoparticle drug carrier. They are mainly used in research settings where it is necessary to study cell interaction or cellular toxicity of the nanoparticles. The most commonly used material for this purpose is Polyethylene Terephthalate (PET). Other materials include polystyrene, dextran, and glass beads among others.
Application Insights:
Medical diagnostics and biosensors were the prominent application segment in the global bioinks market, accounting for over 40% of revenue share in 2015. The growth of this segment is attributed to rising demand for rapid diagnostic tests that are sensitive and specific against various pathogens.
Tissue engineering was another important application sector witnessing significant demand from medical applications across the globe owing to its ability to repair or replace diseased or damaged tissue. Bioink-based tissues have been used successfully in numerous clinical trials and are being considered as a potential alternative therapy for treating several chronic conditions such as cardiovascular disease, diabetes mellitus type 2, osteoarthritis, rheumatoid arthritis & osteoporosis among others.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing R&D investments and supportive government initiatives. Asia Pacific is anticipated to witness lucrative growth over the next eight years owing to rising healthcare spending, improving economic conditions, and growing patient awareness levels regarding available treatment options. Moreover, rapidly developing medical tourism industry in emerging countries such as China & India are expected favorably impact overall revenue generation in this region. Matrix bioinks generated significant revenue share within Asia Pacific regional market owing to their high demand from research laboratories for use in tissue engineering applications across various disease states including diabetes (matrix-seeded hydrogel), cancer (matrix-seeded culture medium), cardiovascular diseases (matrix-bound cells) & neurological disorders (neurite outgrowth).
Latin America also contributed significantly towards overall revenue generation through matrix bioink segment on account of rising interest of pharmaceutical companies for clinical trials involving human subjects outside U.S.
Growth Factors:
- Increasing demand for bioinks from the medical sector for printing tissues and organs
- Rising number of research activities on bioinks that would improve their properties
- Growing investments by key players in the R&D of bioinks to widen their application areas
- Proliferation of 3D printing technology across various industry verticals
- Emergence of new start-ups focused on developing innovative bioinks
Scope Of The Report
Report Attributes
Report Details
Report Title
Bioinks Market Research Report
By Type
Matrix Bioinks, Sacrificial Bioinks, Support Bioinks, Others
By Application
Tissue Engineering, Drug Delivery, Medical Diagnostics and Biosensors, Structural Genomics, Other
By Companies
Cellink, Allevi, Biogelx, UPM Biomedicals, CollPlant, Brinter, XPECT-INX, Zanasi Srl, regenHU, SunP Biotech, StemEasy, Bioink solutions,inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
170
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global Bioinks Market Report Segments:
The global Bioinks market is segmented on the basis of:
Types
Matrix Bioinks, Sacrificial Bioinks, Support Bioinks, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tissue Engineering, Drug Delivery, Medical Diagnostics and Biosensors, Structural Genomics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cellink
- Allevi
- Biogelx
- UPM Biomedicals
- CollPlant
- Brinter
- XPECT-INX
- Zanasi Srl
- regenHU
- SunP Biotech
- StemEasy
- Bioink solutions,inc
Highlights of The Bioinks Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Matrix Bioinks
- Sacrificial Bioinks
- Support Bioinks
- Others
- By Application:
- Tissue Engineering
- Drug Delivery
- Medical Diagnostics and Biosensors
- Structural Genomics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bioinks Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bioinks are a type of medical waste that is made up of biological materials such as blood, tissue, and urine. Bioinks are used in the manufacturing of medical devices and other products.
Some of the major companies in the bioinks market are Cellink, Allevi, Biogelx, UPM Biomedicals, CollPlant, Brinter, XPECT-INX, Zanasi Srl, regenHU, SunP Biotech, StemEasy, Bioink solutions,inc.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bioinks Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bioinks Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bioinks Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bioinks Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bioinks Market Size & Forecast, 2018-2028
4.5.1 Bioinks Market Size and Y-o-Y Growth
4.5.2 Bioinks Market Absolute $ Opportunity
Chapter 5 Global Bioinks Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Bioinks Market Size Forecast by Type
5.2.1 Matrix Bioinks
5.2.2 Sacrificial Bioinks
5.2.3 Support Bioinks
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Bioinks Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Bioinks Market Size Forecast by Applications
6.2.1 Tissue Engineering
6.2.2 Drug Delivery
6.2.3 Medical Diagnostics and Biosensors
6.2.4 Structural Genomics
6.2.5 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bioinks Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bioinks Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Bioinks Analysis and Forecast
9.1 Introduction
9.2 North America Bioinks Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Bioinks Market Size Forecast by Type
9.6.1 Matrix Bioinks
9.6.2 Sacrificial Bioinks
9.6.3 Support Bioinks
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Bioinks Market Size Forecast by Applications
9.10.1 Tissue Engineering
9.10.2 Drug Delivery
9.10.3 Medical Diagnostics and Biosensors
9.10.4 Structural Genomics
9.10.5 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Bioinks Analysis and Forecast
10.1 Introduction
10.2 Europe Bioinks Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Bioinks Market Size Forecast by Type
10.6.1 Matrix Bioinks
10.6.2 Sacrificial Bioinks
10.6.3 Support Bioinks
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Bioinks Market Size Forecast by Applications
10.10.1 Tissue Engineering
10.10.2 Drug Delivery
10.10.3 Medical Diagnostics and Biosensors
10.10.4 Structural Genomics
10.10.5 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Bioinks Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Bioinks Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Bioinks Market Size Forecast by Type
11.6.1 Matrix Bioinks
11.6.2 Sacrificial Bioinks
11.6.3 Support Bioinks
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Bioinks Market Size Forecast by Applications
11.10.1 Tissue Engineering
11.10.2 Drug Delivery
11.10.3 Medical Diagnostics and Biosensors
11.10.4 Structural Genomics
11.10.5 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Bioinks Analysis and Forecast
12.1 Introduction
12.2 Latin America Bioinks Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Bioinks Market Size Forecast by Type
12.6.1 Matrix Bioinks
12.6.2 Sacrificial Bioinks
12.6.3 Support Bioinks
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Bioinks Market Size Forecast by Applications
12.10.1 Tissue Engineering
12.10.2 Drug Delivery
12.10.3 Medical Diagnostics and Biosensors
12.10.4 Structural Genomics
12.10.5 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Bioinks Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Bioinks Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Bioinks Market Size Forecast by Type
13.6.1 Matrix Bioinks
13.6.2 Sacrificial Bioinks
13.6.3 Support Bioinks
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Bioinks Market Size Forecast by Applications
13.10.1 Tissue Engineering
13.10.2 Drug Delivery
13.10.3 Medical Diagnostics and Biosensors
13.10.4 Structural Genomics
13.10.5 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bioinks Market: Competitive Dashboard
14.2 Global Bioinks Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Cellink
14.3.2 Allevi
14.3.3 Biogelx
14.3.4 UPM Biomedicals
14.3.5 CollPlant
14.3.6 Brinter
14.3.7 XPECT-INX
14.3.8 Zanasi Srl
14.3.9 regenHU
14.3.10 SunP Biotech
14.3.11 StemEasy
14.3.12 Bioink solutions,inc
